Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
2016/0339133 BATTERY POWERED UV SANITATION SYSTEM
An ultraviolet radiation sanitation system which is portable and which operates on battery power to generate UVC radiation to decontaminate bathrooms on...
2016/0339132 SYSTEMS AND METHODS FOR SANITIZING SURFACES
Systems and methods for sanitization of surfaces, such as hands, are provided. In general, the described techniques utilize a system including a housing having...
2016/0339131 ODOR REMOVAL ASSEMBLY
An odor removal assembly comprising a container that, when open, allows a user to place items into the bag's interior, and when closed, prevents a user from...
2016/0339130 ASEPTIC MANIPULATION SYSTEM
A decontamination operation chamber is partitioned into a first operation chamber and a second operation chamber. A connecting portion that connects the first...
2016/0339129 GENERATION OF MICROBIOCIDE INSIDE A PACKAGE UTILIZING A CONTROLLED GAS COMPOSITION
An apparatus and method of producing an atmospheric non-equilibrium plasma (ANEP) in a sealed container having a selected working gas and an object to be...
2016/0339128 LIQUID TREATMENT METHOD AND LIQUID TREATMENT APPARATUS FOR TREATING A LIQUID WITH PLASMA
A liquid treatment method according to an aspect of the present disclosure comprises: starting application of a power between a pair of electrodes to generate...
2016/0339127 UV DISINFECTION SYSTEM FOR NEEDLELESS CONNECTOR
A device is presented for disinfecting needleless connectors. The device has a housing that contains a UV light source. The UV light source is operably...
2016/0339126 ULTRAVIOLET DISINFECTION SYSTEM FOR ATHLETIC ITEMS
An ultraviolet disinfection system to generate UVC radiation inside athletic clothing, gear and other items to be decontaminated. The system includes a...
2016/0339125 DISPERSIONS COMPRISING DISCRETE CARBON NANOTUBE FIBERS
This present invention relates to the carbon nanotubes as composites with materials such as elastomers, thermosets and thermoplastics or aqueous dispersions of...
2016/0339124 RADIOLABELED TRACERS FOR POLY (ADP-RIBOSE) POLYMERASE-1 (PARP-1), METHODS AND USES THEREFOR
Disclosed arc PARP-1 inhibitors, which can be .sup.18P-labeled for use as tracers in positron emission tomographic (PET) imaging. Further disclosed are methods...
2016/0339123 POLYBUTYLACRYLATE-BASED NANOCOMPOSITE PHOTOACOUSTIC IMAGING AGENT AND A PREPARATION METHOD THEREOF
A polybutylacrylate-based nanocomposite photoacoustic imaging agent includes a biomedical material such as polybutylacrylate used as a main component and...
2016/0339122 SYNTHESIS AND COMPOSITION OF AMINO ACID LINKING GROUPS CONJUGATED TO COMPOUNDS USED FOR THE TARGETED IMAGING OF...
The present disclosure relates to compounds that are useful as near-infrared fluorescence probes, wherein the compounds include i) a pteroyl ligand that binds...
2016/0339121 NOVEL ANIMAL MODELS FOR EVALUATING PHARMACEUTICAL COMPOUNDS
The application relates to methods for determining a parameter such as toxicity and pharmacokinetic behavior for a pharmaceutical compound against a disease or...
2016/0339120 PROGRAMMABLE BACTERIAL TATTOO
This disclosure relates to a tattoo decal containing bacteria that can be applied to skin and function as both a monitoring sensor and a visual indicator. In...
2016/0339119 METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER
The technology described herein is directed to agonists of e.g. Esr2, Dlx5, and/or Egr3, for the inhibition of cancer cells (e.g. squamous carcinoma cancer...
2016/0339118 Carrier-Antibody Compositions and Methods of Making and Using the Same
Described herein are compositions of antibodies and carrier proteins and methods of making and using the same, in particular, as a cancer therapeutic. Also...
2016/0339117 BCL-XL Inhibitory Compounds Having Low Cell Permeability and Antibody Drug Conjugates Including the Same
The present disclosure concerns Bcl-xL inhibitors having low cell permeability, antibody drug conjugates (ADCs) comprising the inhibitors, synthons useful for...
2016/0339116 Molecular constructs with targeting and effector moieties for treating infectious diseases
The present disclosure provides various molecular constructs having a targeting element and an effector element. Methods for treating various diseases using...
2016/0339115 Molecular constructs with targeting and effector moieties for treating central nervous system diseases
The present disclosure provides various molecular constructs having a targeting element and an effector element. Methods for treating various diseases using...
2016/0339114 TUBULYSIN DERIVATIVES
Novel tubulysin derivatives which may be useful as cytotoxic agents to provide therapeutic benefits in the treatment of various types of cancers, alone, as...
2016/0339113 MICROVESSEL ENDOTHELIAL CELL SURFACE MARKERS AND USES THEREOF
Disclosed herein are microvessel endothelial cell surface markers and methods, compositions, agents, and kits relating to those surface markers.
2016/0339112 ANTIMICROBIAL COMPOSITIONS COMPRISING SINGLE DOMAIN ANTIBODIES AND PSEUDOMONAS EXOTOXIN
The present invention provides heavy chain immunoglobulins of the VHH type or fragment thereof having affinity for a target antigen of interest, including...
2016/0339111 Peptide core-based multi-arm linkers for treating infectious diseases
The present disclosure provides various molecular constructs having a targeting element and an effector element. Methods for treating various diseases using...
2016/0339110 Peptide core-based multi-arm linkers for treating central nervous system diseases
The present disclosure provides various molecular constructs having a targeting element and an effector element. Methods for treating various diseases using...
2016/0339109 Peptide core-based multi-arm linkers and their applications
The present disclosure provides various molecular constructs having a targeting element and an effector element. Methods for treating various diseases using...
2016/0339108 OLIGOMER-CONTAINING BENZAMIDE-BASED COMPOUNDS
The invention relates to (among other things) oligomer-containing benzamide-based compound compounds. A compound of the invention exhibits one or more...
2016/0339107 OPTIMIZED IN VIVO DELIVERY SYSTEM WITH ENDOSOMOLYTIC AGENTS FOR NUCLEIC ACID CONJUGATES
The present invention relates to an optimized in vivo delivery system with endosomolytic agents for nucleic acid of therapeutic interest conjugated to...
2016/0339106 PRECISE DELIVERY OF THERAPEUTIC AGENTS TO CELL MITOCHONDRIA FOR ANTI-CANCER THERAPY
Described is a targeted molecular scaffold for construction of a metabolic inhibitor loaded with cancer-cell specific activity and anti-tumor immunity....
2016/0339105 PHARMACEUTICAL COMPOSITION COMPRISING BRINZOLAMIDE
A sterile aqueous formulation of a carbonic anhydrase inhibitor such as brinzolamide in combination with polymers like Soluplus.RTM. and a surfactant like...
2016/0339104 Pre-Mixed, Ready-To-Use Pharmaceutical Compositions
Provided herein are ready-to-use premixed pharmaceutical compositions of nicardipine or a pharmaceutically acceptable salt and methods for use in treating...
2016/0339103 Functional Micelles for Hard Tissue Targeted Delivery of Chemicals
Compositions and methods for targeting agents to hard tissue are provided.
2016/0339102 SELF-BUFFERING PROTEIN FORMULATIONS
The invention herein described, provides, among other things, self-buffering protein formulations. Particularly, the invention provides self-buffering...
2016/0339101 COMBINATION THERAPY INVOLVING ANTIBODIES AGAINST CLAUDIN 18.2 FOR TREATMENT OF CANCER
The present invention provides a combination therapy for effectively treating and/or preventing diseases associated with cells expressing CLDN18.2, including...
2016/0339100 AFUCOSYLATED ANTI-FGFR2IIIB ANTIBODIES
The present invention provides antibodies that bind FGFR2IIIb, wherein the antibodies are afucosylated. The present invention provides compositions comprising...
2016/0339099 SYNERGISTIC COMBINATION OF ANALGESIC DRUGS
The present invention relates a pharmaceutical composition comprising (a) an opioid analgesic drug and/or an enkephalinase inhibitor, and (b) a selective...
2016/0339098 Novel compositions and methods for immunotherapies comprising small molecule integrin receptor-ligand agonist...
Small molecule integrin ligand mimetics facilitate integrin-ligand interactions, which may be used to prepare vaccines, adoptive cell therapies,...
2016/0339097 CORONAVIRUS PROTEINS AND ANTIGENS
Disclosed herein are embodiments of a method for collecting, extracting or eluting proteins and antigens from cells infected with coronavirus. The coronavirus...
2016/0339096 RECOMBINANT LOW VIRULENCE BOVINE HERPESVIRUS-1 (BOHV-1) VACCINE VECTORS
The present disclosure teaches generally in the field of vaccination and disease control in cattle and bovine animals. A recombinant bovine herpesvirus 1...
2016/0339095 BACTERIAL LIVE VECTOR VACCINES EXPRESSING CHROMOSOMALLY-INTEGRATED FOREIGN ANTIGENS
Bacterial live vector vaccines represent a vaccine development strategy that offers exceptional flexibility. In the present invention, genes encoding...
2016/0339094 BACTERIAL INFLUENCE OF HOST FEEDING AND EMOTION VIA CLPB PROTEIN MIMICRY OF A-MSH
The present invention relates to bacterial Clp B protein and Clp B expressing bacteria and their impact on diseases or disorders related to reduced appetite,...
2016/0339093 LIVE ATTENUATED CATFISH VACCINE AND METHOD OF MAKING
Live attenuated bacteria vaccines against enteric septicemia of fish, especially catfish, and methods related to the same. Mutant strains of the bacteria...
2016/0339092 NOVEL PEPTIDES AND COMBINATION OF PEPTIDES AND SCAFFOLDS THEREOF FOR USE IN IMMUNOTHERAPY AGAINST COLORECTAL...
The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates...
2016/0339091 METHODS AND COMPOSITIONS FOR ENHANCED CELLULAR SELECTIVITY USING NANOCARRIER-ASSOCIATED LIGANDS
The presently disclosed subject matter provides methods and compositions for activation of clustered receptors on a target cell using nanocarrier-associated...
2016/0339090 COMBINATION THERAPY WITH NEOANTIGEN VACCINE
The present invention relates to neoplasia vaccine or immunogenic composition administered in combination with other agents, such as checkpoint blockade...
2016/0339089 IMMUNOGENIC/THERAPEUTIC GLYCOCONJUGATE COMPOSITIONS AND USES THEREOF
The present disclosure encompasses immunogenic/therapeutic compositions including Globo H-KLH glycoconjugates (OBI-822) and/or therapeutic adjuvants...
2016/0339088 REDUCTION OF ADIPOSE TISSUE
The amount of adipose tissue, including lipomas, at selected locations in the body is reduced by introducing collagenase or collagenase plus another proteinase...
2016/0339087 NOVEL TREATMENTS
The present invention provides polypeptides having protease activity for use in the treatment or prevention of microbial infections in a subject with or...
2016/0339086 COMPOSITIONS AND METHODS FOR TREATING THYROID DISEASE
The present disclosure relates to a compound and method of using such compound preferably in the form of a dietary supplement that, when administered, is...
2016/0339085 PHARMACEUTICAL COMPOSITION CONTAINING A MIXTURE OF PROENZYMES AND ENZYMES
Pharmaceutical composition containing a mixture of proenzymes and enzymes, containing proenzymes trypsinogen and chymotrypsinogen and enzymes ct-amylase and...
2016/0339084 Long-Acting Formulations of Insulin
The application relates to an aqueous pharmaceutical formulation comprising 200-1000 U/mL [equimolar to 200-1000 IU human insulin] of insulin glargine.
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.